Survival Rate Prediction of Nasopharyngeal Carcinoma Patients based on MRI and Gene Expression using Deep Neural Network.
Qihao ZhangGang WuQianyu YangGanmian DaiTiansheng LiPianpian ChenJiao LiWei-Yuan HuangPublished in: Cancer science (2022)
To achieve better treatment regimen and follow-up assessment design for intensity-modulated radiotherapy (IMRT) treated nasopharyngeal carcinoma (NPC) patients, an accurate progression free survival (PFS) time prediction algorithm is needed. We propose to develop PFS prediction model of NPC patients after IMRT treatment using deep learning method, and to compare that with traditional texture analysis method. 151 NPC patients were included in this retrospective study. T1 weighted, proton density and dynamic contrast enhanced MR images were acquired. Expression level of five genes (HIF-1α, EGFR, PTEN, Ki-67, VEGF) and infection of Epstein-Barr virus were tested. A residual network was trained to predict PFS from magnetic resonance (MR) images. The output as well as patient characteristics were combined using linear regression model to give a final PFS prediction. The prediction accuracy was compared with traditional texture analysis method. Regression model combining deep learning output with HIF-1α expression and EB infection gives the best PFS prediction accuracy (Spearman correlation R 2 =0.53; Harrell's C-index = 0.82; ROC analysis AUC=0.88; log rank test HR= 8.45), higher than regression model combining texture analysis with HIF-1α expression (Spearman correlation R 2 =0.14; Harrell's C-index =0.68; ROC analysis AUC=0.76; log rank test HR= 2.85). Deep learning method doesn't require manually drawn tumor ROI, thus is fully automatic. MR image processing using deep learning combined with patient characteristics can provide accurate PFS prediction for nasopharyngeal carcinoma patients and doesn't rely on specific kernels or tumor ROI as texture analysis method.
Keyphrases
- patient reported outcomes
- deep learning
- magnetic resonance
- gene expression
- contrast enhanced
- end stage renal disease
- epstein barr virus
- machine learning
- small cell lung cancer
- chronic kidney disease
- convolutional neural network
- peritoneal dialysis
- ejection fraction
- squamous cell carcinoma
- dna methylation
- newly diagnosed
- cell proliferation
- body composition
- artificial intelligence
- early stage
- prognostic factors
- optical coherence tomography
- diffuse large b cell lymphoma
- rectal cancer
- binding protein
- bioinformatics analysis